Long-term outcomes of the Coordinated Care Program in Patients after Myocardial Infarction (KOS-MI)

Aleksandra Kolarczyk-Haczyk1, Marta Konopko2, Marta Mazur2

  • 13rd Department of Invasive Cardiology, Angiology and Electrophysiology, American Heart of Poland, Dąbrowa Górnicza, Poland.

Kardiologia Polska
|April 25, 2023
PubMed

Insights

The Coordinated Care in Myocardial Infarction Program (KOS-MI) significantly reduces major adverse cardiac events and mortality in heart attack patients. This comprehensive program improves long-term prognosis after myocardial infarction (MI).

Area of Science:

  • Cardiology
  • Public Health
  • Clinical Research

Background:

  • The Coordinated Care in Myocardial Infarction Program (KOS-MI) aims to enhance patient outcomes post-myocardial infarction (MI).
  • The program integrates complete revascularization with continuous cardiac care, rehabilitation, and electrotherapy.

Purpose of the Study:

  • To evaluate the effectiveness of the KOS-MI program.
  • To assess major adverse cardiac and cerebrovascular events (MACCE) at 3-year follow-up.

Main Methods:

  • A retrospective, multicenter registry study comparing KOS-MI patients (n=963) with a standard care control group (n=1009).
  • Propensity score matching (PSM) was used to adjust for baseline differences.
  • MACCE (death, MI, stroke, revascularization) and heart failure hospitalizations were analyzed at 3 years.

Main Results:

  • KOS-MI patients were younger and more likely to have ST-segment elevation myocardial infarction (STEMI).
  • After PSM, the KOS-MI group showed a 25% reduction in MACCE (P=0.008) and a 38% reduction in mortality (P=0.008).
  • Significant reductions were also observed in repeated revascularization (29%) and heart failure hospitalizations (28%) in the KOS-MI group.

Conclusions:

  • The KOS-MI program, combining advanced invasive techniques, complete revascularization, and comprehensive cardiac care, improves long-term prognosis for MI patients.
  • This integrated approach leads to better clinical outcomes and reduced adverse events at 3-year follow-up.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
17
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
14
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
16
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
13
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
18